Literature DB >> 29673620

Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans.

Anya K Bershad1, Melissa A Miller2, Greg J Norman3, Harriet de Wit4.   

Abstract

Both preclinical and clinical evidence suggests that the endogenous opioid system is involved in responses to stress. For example, in animal models opioid agonists reduce isolation distress whereas opioid antagonists increase isolation distress. We recently reported that the mixed mu agonist and kappa antagonist buprenorphine dampened responses to acute psychosocial stress in humans. Now we extend this to study the effects of a pure mu-opioid agonist, hydromorphone, and a non-opioid analgesic, acetaminophen, on response to social stress. We compared the effect of hydromorphone (2 and 4 mg), acetaminophen (1000 mg) to a placebo using a between subject design. Healthy adult volunteers were randomly assigned to receive placebo (N = 13), 2 mg hydromorphone (N = 12), 4 mg hydromorphone (N = 12), or 1000 mg acetaminophen (paracetamol; N = 13) under double-blind conditions before undergoing a stress task or a control task on two separate sessions. The stress task, consisting of a standardized speaking task and the non-stressful control task were presented in counterbalanced order. Dependent measures included mood ratings, subjective appraisal of the stress (or no-stress) task, salivary cortisol, pupil diameter, heart rate, and blood pressure. The stress task produced its expected increase in heart rate, blood pressure, salivary cortisol, pupil diameter, and subjective ratings of anxiety and negative mood. Hydromorphone dose-dependently dampened cortisol responses to stress, and decreased ratings of how "challenging" participants found the task. Acetaminophen did not affect physiological responses, but, like hydromorphone, decreased ratings of how "challenging" the task was. The hydromorphone results support the idea that the mu-opioid system is involved in physiological responses to acute stress in humans, in line with results from preclinical studies. The non-opioid analgesic acetaminophen did not dampen physiological responses, but did reduce some components of psychological stress. It remains to be determined how both opioid and non-opioid systems mediate the complex physiological and psychological responses to social stress.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Hydromorphone; Opioids; Stress; Trier Social Stress Test

Mesh:

Substances:

Year:  2018        PMID: 29673620      PMCID: PMC6004330          DOI: 10.1016/j.yhbeh.2018.04.009

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  72 in total

1.  Effects of buprenorphine on responses to social stimuli in healthy adults.

Authors:  Anya K Bershad; Jacob A Seiden; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

2.  Opioids: from physical pain to the pain of social isolation.

Authors:  Dan J Stein; Jack van Honk; Jonathan Ipser; Mark Solms; Jaak Panksepp
Journal:  CNS Spectr       Date:  2007-09       Impact factor: 3.790

3.  Naltrexone increases negatively-valenced facial responses to happy faces in female participants.

Authors:  Isabell M Meier; Peter A Bos; Katie Hamilton; Dan J Stein; Jack van Honk; Susan Malcolm-Smith
Journal:  Psychoneuroendocrinology       Date:  2016-08-23       Impact factor: 4.905

4.  Acetaminophen attenuates error evaluation in cortex.

Authors:  Daniel Randles; Julia W Y Kam; Steven J Heine; Michael Inzlicht; Todd C Handy
Journal:  Soc Cogn Affect Neurosci       Date:  2016-02-17       Impact factor: 3.436

5.  The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress.

Authors:  Rachel Y Chong; Lynn Oswald; Xiaoju Yang; Magdalena Uhart; Ping-I Lin; Gary S Wand
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

6.  Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.

Authors:  William R Lovallo; Mary-Anne Enoch; Ashley Acheson; Andrew J Cohoon; Kristen H Sorocco; Colin A Hodgkinson; Andrea S Vincent; David C Glahn; David Goldman
Journal:  Neuropsychopharmacology       Date:  2015-04-16       Impact factor: 7.853

Review 7.  Acetaminophen (paracetamol) oral absorption and clinical influences.

Authors:  Robert B Raffa; Joseph V Pergolizzi; Robert Taylor; John F Decker; Jeffrey T Patrick
Journal:  Pain Pract       Date:  2013-10-28       Impact factor: 3.183

8.  The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain.

Authors:  L A Pini; M Sandrini; G Vitale
Journal:  Eur J Pharmacol       Date:  1996-07-11       Impact factor: 4.432

9.  Sex differences in emotional and physiological responses to the Trier Social Stress Test.

Authors:  Megan M Kelly; Audrey R Tyrka; George M Anderson; Lawrence H Price; Linda L Carpenter
Journal:  J Behav Ther Exp Psychiatry       Date:  2007-03-12

10.  From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain.

Authors:  Dominik Mischkowski; Jennifer Crocker; Baldwin M Way
Journal:  Soc Cogn Affect Neurosci       Date:  2016-05-05       Impact factor: 3.436

View more
  9 in total

1.  Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.

Authors:  Kathryne Van Hedger; Anya K Bershad; Royce Lee; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

2.  Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use.

Authors:  Sarah D Lichenstein; Yasmin Zakiniaeiz; Sarah W Yip; Kathleen A Garrison
Journal:  Curr Addict Rep       Date:  2019-04-27

3.  Stressful life events and prescription opioid use during pregnancy: findings from the 2019 pregnancy risk assessment monitoring system.

Authors:  Alexander Testa; Allison D Crawford; Dylan B Jackson; Alison Gemmill
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-08-10       Impact factor: 4.519

4.  Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder.

Authors:  Amanda B Namchuk; Irwin Lucki; Caroline A Browne
Journal:  Adv Drug Alcohol Res       Date:  2022-02-21

5.  Behavioral strategies to reduce stress reactivity in opioid use disorder: Study design.

Authors:  R Kathryn McHugh; Minh D Nguyen; Garrett M Fitzmaurice; Daniel G Dillon
Journal:  Health Psychol       Date:  2020-09       Impact factor: 4.267

Review 6.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

7.  Opioid-blunted cortisol response to stress is associated with increased negative mood and wanting of social reward.

Authors:  Claudia Massaccesi; Matthaeus Willeit; Boris B Quednow; Urs M Nater; Claus Lamm; Daniel Müller; Giorgia Silani
Journal:  Neuropsychopharmacology       Date:  2022-02-09       Impact factor: 8.294

8.  Exploring stress, cognitive, and affective mechanisms of the relationship between interpersonal trauma and opioid misuse.

Authors:  Jessica Roberts Williams; Veronica Cole; Susan Girdler; Martha Grace Cromeens
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

Review 9.  The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.

Authors:  Isabell M Meier; Marie Eikemo; Siri Leknes
Journal:  Curr Addict Rep       Date:  2021-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.